Healthcare

Guidehouse Adds Two Leaders to Growing Health Segment

Mark Korth and Angela Hunt, RN, join as partners to help healthcare organizations advance clinical and operational performance MCLEAN, Va.,…

2 months ago

Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations SEOUL,…

2 months ago

After 20 Years of Advocacy, First Exercise Prescription AI Software Set to Launch in December

VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ - Ginkgo Health Inc., a pioneering technology startup aiming to reduce the global healthcare…

2 months ago

datma Joins GOAL Consortium as a Key Industry Supporter, Advancing Innovation in Academic Genomics and Precision Medicine

BEAVERTON, Ore., Nov. 18, 2024 /PRNewswire/ -- datma, a leading provider of federated Real-World Data platform and related analytical tools, today…

2 months ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

OPKO Healthcare's Veterinary Care Products to be Introduced at Asia's Largest Health and Nutrition Tradeshow Company Invited to Present at…

2 months ago

Semler Scientific® Announces BTC and ATM Activity Raised $21.5 million; Purchased Additional 215 BTC; Now Holds 1,273 BTC with BTC Yield of 37.3%

SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology…

2 months ago

EW Healthcare Partners Announces Leadership Evolution

Dr. Petri Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding…

2 months ago

Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives

NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company…

2 months ago

EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome

EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel…

2 months ago